Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1550062

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1550062

Heart Valve Repair and Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

PUBLISHED:
PAGES: 308 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4900
PDF & Excel (Multi User License)
USD 6400
PDF & Excel (Corporate User License)
USD 7400

Add to Cart

Persistence Market Research has recently released a detailed report on the global heart valve repair and replacement market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

  • Heart Valve Repair and Replacement Market Size (2024E): US$ 8506.34 Mn
  • Projected Market Value (2031F): US$ 16968.01 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 10.4%

Heart Valve Repair & Replacement Market - Report Scope:

The heart valve repair and replacement market focuses on devices and technologies used to repair or replace damaged heart valves, ensuring the proper flow of blood through the heart. The market growth is driven by the rising prevalence of cardiac disorders, the aging population, and advancements in minimally invasive surgical techniques. These factors are contributing to the increasing demand for heart valve repair and replacement procedures globally.

Market Growth Drivers:

The global heart valve repair and replacement market is driven by several key factors, including the rising prevalence of cardiac disorders such as aortic stenosis and rheumatic heart disease. The growing incidence of these conditions, particularly among the elderly, is fueling the demand for heart valve repair and replacement. Additionally, the healthcare system is rapidly evolving, with institutions adopting new technologies and improving patient care through better treatments, medications, and therapies. Government initiatives supporting healthcare improvements, along with favorable reimbursement policies and flexible insurance claims, are also contributing to market growth. Another significant driver is the increased usage of data-driven technologies in developing heart valves. Manufacturers are leveraging hospital data and implementing advanced technologies such as IoT and artificial intelligence to design smart, high-quality heart valves. The adoption of these technologies is expected to drive market growth in the coming years by enhancing the precision and effectiveness of heart valve repair and replacement procedures.

Market Restraints:

Despite the strong growth potential, the heart valve repair and replacement market faces several challenges. One of the primary restraints is the risk associated with heart valve replacement procedures, which are invasive and carry significant risks such as excessive bleeding, arrhythmia, stroke, renal issues, and infections. Although minimally invasive techniques offer lower risks, the cost of these procedures is relatively high compared to traditional invasive surgery, which can deter some patients from opting for surgery. These risks and costs are likely to impact the market's growth, particularly in regions with limited access to advanced healthcare services.

Market Opportunities:

The heart valve repair and replacement market presents substantial growth opportunities driven by advancements in healthcare infrastructure and the increasing adoption of minimally invasive procedures. The growing awareness of cardiovascular diseases and the availability of advanced treatment options are expected to boost the demand for heart valve repair and replacement. Additionally, continuous innovations in valve design and the integration of data-driven technologies will create new opportunities for market players to develop next-generation heart valves that offer improved outcomes and reduced risks for patients.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the heart valve repair and replacement market globally?
  • Which types of heart valves and surgical techniques are leading the demand in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the heart valve repair and replacement market?
  • Who are the key players in the heart valve repair and replacement market, and what strategies are they employing to enhance their market presence?
  • What are the emerging trends and future prospects in the global heart valve repair and replacement market?

Competitive Intelligence and Business Strategy:

Leading players in the global heart valve repair and replacement market, including companies such as Edwards Lifesciences, Medtronic, and Abbott Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced heart valve technologies, such as transcatheter aortic valve replacement (TAVR) and minimally invasive mitral valve repair. Collaborations with hospitals and research institutions facilitate the adoption of these technologies and improve patient outcomes. Emphasis on data-driven innovation, cost-effective solutions, and expanding access to advanced surgical options drives growth and strengthens market positioning in the dynamic heart valve repair and replacement industry.

Key Companies Profiled:

  • Medtronic
  • Abbott
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • LivaNova PLC
  • Colibri Heart Valve
  • JenaValve Technology, Inc.
  • Micro Interventional Devices, Inc.
  • Braile Biomedica
  • Arbor Surgical Technologies, Inc.
  • Aortech International Plc

Heart Valve Repair Replacement Market Categorization

Heart Valve Repair Replacement Market by By Product

  • Heart Valve Repair
  • Heart Valve Replacement
  • Tissue Heart Valves
  • Transcatheter Aortic Valve Implantation (TAVI)

Heart Valve Repair Replacement Market By Indication

  • Aortic Stenosis
  • Aortic Regurgitation
  • Mitral Stenosis
  • Mitral Regurgitation

Heart Valve Repair Replacement Market By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

Heart Valve Repair Replacement Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)
Product Code: PMRREP3192

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends
  • 3.3. Regulatory Scenario

4. Key Success Factors

  • 4.1. Reimbursement Scenario
  • 4.2. Heart Valve Procedure Statistics, 2019

5. Global Heart Valve Repair and Replacement Market - Pricing Analysis

  • 5.1. Country Pricing Analysis By Product Type
  • 5.2. Pricing Break-up
    • 5.2.1. Manufacturer Level Pricing
    • 5.2.2. Distributor Level Pricing
  • 5.3. Global Average Pricing Analysis Benchmark

6. Global Economic Outlook

  • 6.1. Gross Domestic Product by Region & Country, 2019-2023
  • 6.2. Global Healthcare Market Outlook

7. Global Heart Valve Repair and Replacement Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Healthcare Expenditure by Country
    • 8.1.3. Regional Healthcare Market Outlook
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Development and commercialization of heart valve therapies
    • 8.2.2. Increasing incidence of congenital heart defects
    • 8.2.3. Rise in geriatric population with structural heart disorders
    • 8.2.4. Varied stringency of regulatory procedures
    • 8.2.5. High costs associated with heart valve repair and replacement procedures
  • 8.3. Value Chain
  • 8.4. Market Dynamics
    • 8.4.1. Drivers
    • 8.4.2. Restraints
    • 8.4.3. Opportunity Analysis

9. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
    • 9.3.1. Heart Valve Repair
      • 9.3.1.1. Mitral Valve Annuloplasty Rings
      • 9.3.1.2. Transcatheter Mitral Valve Repair (TMVR)
    • 9.3.2. Heart Valve Replacement
      • 9.3.2.1. Mechanical Heart Valves
        • 9.3.2.1.1. Mechanical Sutured Aortic Valve Replacements
        • 9.3.2.1.2. Mechanical Sutured Mitral Valve Replacements
      • 9.3.2.2. Tissue Heart Valves
        • 9.3.2.2.1. Tissue Sutured Aortic Valve Replacements
        • 9.3.2.2.2. Tissue Sutured Mitral Valve Replacements
        • 9.3.2.2.3. Tissue Sutureless Aortic Valve Replacements
      • 9.3.2.3. Transcatheter Aortic Valve Implantation (TAVI)
  • 9.4. Market Attractiveness Analysis By Product Type

10. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Disease Indication

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2024-2031
    • 10.3.1. Aortic Stenosis
    • 10.3.2. Aortic Regurgitation
    • 10.3.3. Mitral Stenosis
    • 10.3.4. Mitral Regurgitation
  • 10.4. Market Attractiveness Analysis By Disease Indication

11. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
    • 11.3.3. Cardiac Catheterization Laboratories
  • 11.4. Market Attractiveness Analysis By End User

12. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Middle East and Africa (MEA)
    • 12.3.5. East Asia
    • 12.3.6. South Asia
    • 12.3.7. Oceania
  • 12.4. Market Attractiveness Analysis By Region

13. North America Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.4.1. By Country
      • 13.4.1.1. U.S.
      • 13.4.1.2. Canada
    • 13.4.2. By Product Type
    • 13.4.3. By Disease Indication
    • 13.4.4. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Disease Indication
    • 13.5.4. By End User
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis

14. Latin America Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. Brazil
      • 14.4.1.2. Mexico
      • 14.4.1.3. Rest of Latin America
    • 14.4.2. By Product Type
    • 14.4.3. By Disease Indication
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Disease Indication
    • 14.5.4. By End User
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis

15. Europe Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Germany
      • 15.4.1.2. Italy
      • 15.4.1.3. France
      • 15.4.1.4. U.K.
      • 15.4.1.5. Spain
      • 15.4.1.6. BENELUX
      • 15.4.1.7. Russia
      • 15.4.1.8. Rest of Europe
    • 15.4.2. By Product Type
    • 15.4.3. By Disease Indication
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Disease Indication
    • 15.5.4. By End User
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis

16. South Asia Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. India
      • 16.4.1.2. Thailand
      • 16.4.1.3. Indonesia
      • 16.4.1.4. Malaysia
      • 16.4.1.5. Rest of South Asia
    • 16.4.2. By Product Type
    • 16.4.3. By Disease Indication
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Disease Indication
    • 16.5.4. By End User
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis

17. East Asia Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. China
      • 17.4.1.2. Japan
      • 17.4.1.3. South Korea
    • 17.4.2. By Product Type
    • 17.4.3. By Disease Indication
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product Type
    • 17.5.3. By Disease Indication
    • 17.5.4. By End User
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis

18. Oceania Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. Australia
      • 18.4.1.2. New Zealand
    • 18.4.2. By Product Type
    • 18.4.3. By Disease Indication
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product Type
    • 18.5.3. By Disease Indication
    • 18.5.4. By End User
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 19.4.1. By Country
      • 19.4.1.1. GCC Countries
      • 19.4.1.2. Northern Africa
      • 19.4.1.3. South Africa
      • 19.4.1.4. Rest of Middle East and Africa
    • 19.4.2. By Product Type
    • 19.4.3. By Disease Indication
    • 19.4.4. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Product Type
    • 19.5.3. By Disease Indication
    • 19.5.4. By End User
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis

20. Emerging Countries Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
    • 20.1.1. Market Value Proportion Analysis, By Key Countries
    • 20.1.2. Global Vs. Country Growth Comparison
  • 20.2. China Heart Valve Repair and Replacement Market Analysis
    • 20.2.1. Introduction
    • 20.2.2. Market Value Proportion Analysis by Market Taxonomy
    • 20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 20.2.3.1. By Product Type
      • 20.2.3.2. By Disease Indication
      • 20.2.3.3. By End User
    • 20.2.4. China Heart Valve Repair and Replacement Market - Competition Landscape
  • 20.3. Japan Heart Valve Repair and Replacement Market Analysis
    • 20.3.1. Introduction
    • 20.3.2. Market Value Proportion Analysis by Market Taxonomy
    • 20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 20.3.3.1. By Product Type
      • 20.3.3.2. By Disease Indication
      • 20.3.3.3. By End User
    • 20.3.4. Japan Heart Valve Repair and Replacement Market - Competition Landscape
  • 20.4. India Heart Valve Repair and Replacement Market Analysis
    • 20.4.1. Introduction
    • 20.4.2. Market Value Proportion Analysis by Market Taxonomy
    • 20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 20.4.3.1. By Product Type
      • 20.4.3.2. By Disease Indication
      • 20.4.3.3. By End User
    • 20.4.4. India Heart Valve Repair and Replacement Market - Competition Landscape

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies (Heart Valve Repair and Replacement)
  • 21.2. Market Concentration
  • 21.3. Market Share Analysis of Top Players
  • 21.4. Market Presence Analysis
    • 21.4.1. By Regional footprint of Players
    • 21.4.2. Product foot print by Players
    • 21.4.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Medtronic
      • 22.2.1.1. Overview
      • 22.2.1.2. Product Portfolio
      • 22.2.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.1.4. Sales Footprint
      • 22.2.1.5. Strategy Overview
        • 22.2.1.5.1. Marketing Strategy
        • 22.2.1.5.2. Product Strategy
        • 22.2.1.5.3. Channel Strategy
    • 22.2.2. Abbott
      • 22.2.2.1. Overview
      • 22.2.2.2. Product Portfolio
      • 22.2.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.2.4. Sales Footprint
      • 22.2.2.5. Strategy Overview
        • 22.2.2.5.1. Marketing Strategy
        • 22.2.2.5.2. Product Strategy
        • 22.2.2.5.3. Channel Strategy
    • 22.2.3. Edwards Lifesciences Corporation
      • 22.2.3.1. Overview
      • 22.2.3.2. Product Portfolio
      • 22.2.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.3.4. Sales Footprint
      • 22.2.3.5. Strategy Overview
        • 22.2.3.5.1. Marketing Strategy
        • 22.2.3.5.2. Product Strategy
        • 22.2.3.5.3. Channel Strategy
    • 22.2.4. Boston Scientific Corporation
      • 22.2.4.1. Overview
      • 22.2.4.2. Product Portfolio
      • 22.2.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.4.4. Sales Footprint
      • 22.2.4.5. Strategy Overview
        • 22.2.4.5.1. Marketing Strategy
        • 22.2.4.5.2. Product Strategy
        • 22.2.4.5.3. Channel Strategy
    • 22.2.5. CryoLife, Inc.
      • 22.2.5.1. Overview
      • 22.2.5.2. Product Portfolio
      • 22.2.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.5.4. Sales Footprint
      • 22.2.5.5. Strategy Overview
        • 22.2.5.5.1. Marketing Strategy
        • 22.2.5.5.2. Product Strategy
        • 22.2.5.5.3. Channel Strategy
    • 22.2.6. LivaNova PLC
      • 22.2.6.1. Overview
      • 22.2.6.2. Product Portfolio
      • 22.2.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.6.4. Sales Footprint
      • 22.2.6.5. Strategy Overview
        • 22.2.6.5.1. Marketing Strategy
        • 22.2.6.5.2. Product Strategy
        • 22.2.6.5.3. Channel Strategy
    • 22.2.7. Colibri Heart Valve
      • 22.2.7.1. Overview
      • 22.2.7.2. Product Portfolio
      • 22.2.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.7.4. Sales Footprint
      • 22.2.7.5. Strategy Overview
        • 22.2.7.5.1. Marketing Strategy
        • 22.2.7.5.2. Product Strategy
        • 22.2.7.5.3. Channel Strategy
    • 22.2.8. JenaValve Technology, Inc.
      • 22.2.8.1. Overview
      • 22.2.8.2. Product Portfolio
      • 22.2.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.8.4. Sales Footprint
      • 22.2.8.5. Strategy Overview
        • 22.2.8.5.1. Marketing Strategy
        • 22.2.8.5.2. Product Strategy
        • 22.2.8.5.3. Channel Strategy
    • 22.2.9. Micro Interventional Devices, Inc.
      • 22.2.9.1. Overview
      • 22.2.9.2. Product Portfolio
      • 22.2.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.9.4. Sales Footprint
      • 22.2.9.5. Strategy Overview
        • 22.2.9.5.1. Marketing Strategy
        • 22.2.9.5.2. Product Strategy
        • 22.2.9.5.3. Channel Strategy
    • 22.2.10. Braile Biomedica
      • 22.2.10.1. Overview
      • 22.2.10.2. Product Portfolio
      • 22.2.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.10.4. Sales Footprint
      • 22.2.10.5. Strategy Overview
        • 22.2.10.5.1. Marketing Strategy
        • 22.2.10.5.2. Product Strategy
        • 22.2.10.5.3. Channel Strategy
    • 22.2.11. Arbor Surgical Technologies, Inc.
      • 22.2.11.1. Overview
      • 22.2.11.2. Product Portfolio
      • 22.2.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.11.4. Sales Footprint
      • 22.2.11.5. Strategy Overview
        • 22.2.11.5.1. Marketing Strategy
        • 22.2.11.5.2. Product Strategy
        • 22.2.11.5.3. Channel Strategy
    • 22.2.12. Aortech International Plc
      • 22.2.12.1. Overview
      • 22.2.12.2. Product Portfolio
      • 22.2.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.12.4. Sales Footprint
      • 22.2.12.5. Strategy Overview
        • 22.2.12.5.1. Marketing Strategy
        • 22.2.12.5.2. Product Strategy
        • 22.2.12.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!